Using AI, researchers identified one tiny molecular interaction that viruses need to infect cells. Disrupting it stopped the virus before infection could begin.
Washington State University scientists have uncovered a method to interfere with a key viral protein, stopping viruses from getting inside cells where they can cause disease. The discovery points toward a possible new strategy for developing antiviral treatments in the future.
The work, published in the journal Nanoscale, involved researchers from the School of Mechanical and Materials Engineering and the Department of Veterinary Microbiology and Pathology. Together, they identified and disrupted a specific molecular interaction that herpes viruses depend on to enter cells.
"Viruses are very smart," said Jin Liu, corresponding author of the study and a professor in the School of Mechanical and Materials Engineering. "The whole process of invading cells is very complex, and there are a lot of interactions. Not all of the interactions are equally important — most of them may just be background noise, but there are some critical interactions."
Targeting the Protein Viruses Use to Break In
The researchers focused on a viral "fusion" protein, which herpes viruses use to attach to cells and merge with them, triggering infection and disease. Scientists still lack a clear understanding of how this large and complicated protein changes shape to allow viruses inside cells. This limited knowledge is one reason vaccines for many common herpes viruses have remained elusive.

How AI Narrowed Down Thousands of Possibilities
To tackle this challenge, the team turned to artificial intelligence and molecular scale simulations. Professors Prashanta Dutta and Jin Liu analyzed thousands of possible interactions within the fusion protein to find a single amino acid that plays a central role in viral entry. They designed an algorithm to examine interactions among amino acids, the basic building blocks of proteins, and then applied machine learning to sort through the data and identify which interactions mattered most.
A Single Mutation That Blocks Infection
Once the key amino acid was identified, laboratory experiments led by Anthony Nicola from the Department of Veterinary Microbiology and Pathology put the findings to the test. By altering that one amino acid, the researchers found that the virus could no longer successfully fuse with cells. As a result, the herpes virus was effectively prevented from entering the cells.
According to Liu, the computational work was essential because testing even one interaction in the lab can take months. Narrowing the focus ahead of time made the experimental phase far more efficient.
"It was just a single interaction from thousands of interactions. If we don't do the simulation and instead did this work by trial and error, it could have taken years to find," said Liu. "The combination of theoretical computational work with the experiments is so efficient and can accelerate the discovery of these important biological interactions."
What Scientists Still Need to Understand
Although the team confirmed the importance of this specific interaction, many questions remain about how changing one amino acid affects the structure of the entire fusion protein. The researchers plan to continue using simulations and machine learning to better understand how small molecular changes influence the protein at larger scales.
"There is a gap between what the experimentalists see and what we can see in the simulation," said Liu. "The next step is how this small interaction affects the structural change at larger scales. That is also very challenging for us."
Reference: "Modulation of specific interactions within a viral fusion protein predicted from machine learning blocks membrane fusion" by Ryan E. Odstrcil, Albina O. Makio, McKenna A. Hull, Prashanta Dutta, Anthony V. Nicola and Jin Liu, 4 November 2025, Nanoscale.
DOI: 10.1039/D5NR03235K
In addition to Liu, Dutta and Nicola, the project was conducted by PhD students Ryan Odstrcil, Albina Makio, and McKenna Hull. The work was funded by the National Institutes of Health.
News
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
Artificial cells gain porous membranes, enabling lab reactions and drug release
Artificial cells created in the laboratory offer a wide range of potential applications. Until now, however, their membranes—unlike those of real cells—have been virtually impermeable. Researchers at the Max Planck Institute for Polymer Research, [...]
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]
Researchers Discover a Hidden Vitamin D Problem That Persists Year-Round
A new study suggests that some groups may not experience the expected seasonal boost in vitamin D levels, even during the sunniest months of the year. Many people assume that spending more time outdoors [...]
Researchers Solve the Mystery Behind a Billion-Dollar Dental Implant Disease
Researchers have uncovered why a common and costly dental implant infection often resists antibiotics. Dental implants have helped tens of millions of people regain a full set of stable, functional teeth, something traditional dentures [...]
Nanoparticles inspired by lung fluid improve therapies targeting respiratory system
The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that line the alveoli and enables breathing), which are encapsulated [...]
Scientists Finally Uncover How a “Forever Chemical” Causes Birth Defects
PFDA, a PFAS “forever chemical,” can cause craniofacial birth defects by disrupting retinoic acid regulation during fetal development, revealing the first clear molecular mechanism behind the link. Researchers have long linked perfluoroalkyl and polyfluoroalkyl substances (PFAS), [...]















